Hyung-Don Kim

22PUBLICATIONS
164CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 06, 2026
Predictive Value of Insertion/Deletion Rate in Patients With Gastric Cancer Treated With Nivolumab Plus Chemotherapy.

Hyung-Don Kim, Hyungeun Lee, Sun Young Lee

|Apr 06, 2026
Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification.

In Hye Song, Soomin Ahn, Hyung-Don Kim

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Feb 11, 2026
Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors.

Seongyeol Park, Kijong Yi, Jieun Lee

|Jan 10, 2026
Neoadjuvant Chemotherapy for Gastric Cancer: Evolving Approaches and Supporting Evidence.

Young Jae Kim, Hyung-Don Kim, Jaewon Hyung

|Mar 13, 2025
Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer.

Yoon-Koo Kang, Hyung-Don Kim, Hyungwoo Cho

Pageof 4

Frequent Collaborators

9 joint publications

Min-Hee Ryu

7 joint publications

Changhoon Yoo

4 joint publications

Baek-Yeol Ryoo

4 joint publications

In-Ho Kim